2016
Abstract TMP21: Effect of Non-evidence Based Practices in Carotid Artery Stenting on Outcomes
Obeid T, Arhuidese I, Malas M. Abstract TMP21: Effect of Non-evidence Based Practices in Carotid Artery Stenting on Outcomes. Stroke 2016, 47 DOI: 10.1161/str.47.suppl_1.tmp21.Peer-Reviewed Original ResearchProximal embolic protectionPrimary stentingEmbolic protectionEffectiveness of primary stentingVascular Quality Initiative (VQI) databasePrimary composite end pointPrimary carotid stentingPrimary stent groupComposite end pointCarotid artery stentingOutcomes of CASMyocardial infarction ratePropensity score matchingAntagonist usePerioperative complicationsP2Y12 antagonistsStented patientsPatient-level factorsStroke/death rateTreated cohortLogistic regression modelsIpsilateral CEAStent groupArtery stentingCarotid stenting
2015
Beta-blocker use is associated with lower stroke and death after carotid artery stenting
Obeid T, Arhuidese I, Gaidry A, Qazi U, Abularrage C, Goodney P, Cronenwett J, Malas M. Beta-blocker use is associated with lower stroke and death after carotid artery stenting. Journal Of Vascular Surgery 2015, 63: 363-369. PMID: 26526052, PMCID: PMC5292260, DOI: 10.1016/j.jvs.2015.08.108.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdrenergic beta-AntagonistsAdultAgedAged, 80 and overAngioplastyCarotid Artery DiseasesChi-Square DistributionDatabases, FactualFemaleHemodynamicsHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioProtective FactorsRetrospective StudiesRisk AssessmentRisk FactorsStentsStrokeTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsCarotid artery stentingBeta-blocker usePostprocedural hypertensionPostprocedural hypotensionBeta-blockersArtery stentingAssociated with postprocedural hypotensionEffect of preoperative medicationOutcomes of carotid artery stentingPredictors of postoperative strokeAssociated with lower strokeSelection of patientsMultivariate logistic regression modelDistal embolic protection useVascular Quality InitiativeMyocardial infarction rateGranular clinical dataMultiple controlled trialsPreoperative medicationsPostoperative strokeBeta blockersPeriprocedural stroke/deathStroke/death rateLogistic regression modelsStroke/death risk